glp-1 and dementia receptor agonists effect on cognitive function in patients with without type 2 diabetes Interest in using GLP-1 medications

Hers recently moved away from compounded GLP-1s and now focuses on brand-name medications only - things like Wegovy, Zepbound, Ozempic, and Mounjaro

JPTs Diabetes Peptide%3b GLP-1 receptor agonists Glucagon-like Peptide 1 (GLP-1) and other GLP-1 receptor agonists have proven to be an effective treatment of Type 2 diabetes and obesity, offering significant benefits

Furthermore, the role of GLP-1 on NAFLD might be explained by effects on body weight, inflammation and OS, and the gutliver axis

the estimated RD for kidney cancer was 0.04% (95% CI, 0.70% to 0.77%), indicating a potential harm, although the CIs remained wide

Wegovy has several other approvals

Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: a randomized controlled trial